Clinical and Pathological Characterization of Mesoamerican

Nephropathy: A New Kidney Disease in Central America

Julia Wijkstrm, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Clinical and Pathological Characterization of Mesoamerican
Nephropathy: A New Kidney Disease in Central America
Julia Wijkstrm, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Clinical and Pathological Characterization of Mesoamerican
Nephropathy: A New Kidney Disease in Central America
Julia Wijkstrm, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Clinical and Pathological Characterization of Mesoamerican
Nephropathy: A New Kidney Disease in Central America
Julia Wijkstrm, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Clinical and Pathological Characterization of Mesoamerican
Nephropathy: A New Kidney Disease in Central America
Julia Wijkstrm, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Clinical and Pathological
Characterization of
Mesoamerican
Nephropathy: A New Kidney
Disease in Central America
Julia Wijkstrm, MD,1 Ricardo
Leiva, MD,2 Carl-Gustaf Elinder,
MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo,
MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5
Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Clinical and Pathological
Characterization of
Mesoamerican
Nephropathy: A New Kidney
Disease in Central America
Julia Wijkstrm, MD,1 Ricardo
Leiva, MD,2 Carl-Gustaf Elinder,
MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo,
MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5
Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Clinical and Pathological Characterization of Mesoamerican
Nephropathy: A New Kidney Disease in Central America
Julia Wijkstrm, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Clinical and Pathological Characterization of Mesoamerican
Nephropathy: A New Kidney Disease in Central America
Julia Wijkstrm, MD,1 Ricardo Leiva, MD,2 Carl-Gustaf Elinder, MD, PhD,1,3
Silvia Leiva, MD,2 Zulma Trujillo, MD,2 Luis Trujillo, MD,2
Magnus Sderberg, MD, PhD,4,5 Kjell Hultenby, PhD,6 and
Annika Wernerson, MD, PhD1,5
2013
Renal Morphology, Clinical Findings, and
Progression Rate in
Mesoamerican Nephropathy
Julia Wijkstrom, MD,1 Marvin Gonzalez-Quiroz,
MD, MSc,2,3 Mario Hernandez, MD,4
Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli
Ring, BS,7
Magnus Soderberg, MD, PhD,7,8 Aurora Arago
n, MD, PhD,2
Carl-Gustaf Elinder, MD, PhD,1 and Annika
Wernerson, MD, PhD1,7
2016
Renal Morphology, Clinical Findings, and Progression Rate in
Mesoamerican Nephropathy
Julia Wijkstrom, MD,1 Marvin Gonzalez-Quiroz, MD, MSc,2,3 Mario
Hernandez, MD,4
Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7
Magnus Soderberg, MD, PhD,7,8 Aurora Arago n, MD, PhD,2
Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7
2016
Renal Morphology, Clinical Findings, and Progression Rate in
Mesoamerican Nephropathy
Julia Wijkstrom, MD,1 Marvin Gonzalez-Quiroz, MD, MSc,2,3 Mario
Hernandez, MD,4
Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7
Magnus Soderberg, MD, PhD,7,8 Aurora Arago n, MD, PhD,2
Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7
2016
Renal Morphology, Clinical Findings, and Progression Rate in
Mesoamerican Nephropathy
Julia Wijkstrom, MD,1 Marvin Gonzalez-Quiroz, MD, MSc,2,3 Mario Hernandez,
MD,4
Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7
Magnus Soderberg, MD, PhD,7,8 Aurora Arago n, MD, PhD,2
Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7
2016
Renal Morphology,
Clinical Findings, and
Progression Rate in
Mesoamerican
Nephropathy
Julia Wijkstrom, MD,1
Marvin Gonzalez-Quiroz,
MD, MSc,2,3 Mario
Hernandez, MD,4
Zulma Trujillo, MD,5 Kjell
Hultenby, PhD,6 Anneli
Ring, BS,7
Magnus Soderberg, MD,
PhD,7,8 Aurora Arago n,
MD, PhD,2
Carl-Gustaf Elinder, MD,
PhD,1 and Annika
Wernerson, MD, PhD1,7
2016
Renal Morphology, Clinical Findings,
and Progression Rate in
Mesoamerican Nephropathy
Julia Wijkstrom, MD,1 Marvin
Gonzalez-Quiroz, MD, MSc,2,3 Mario
Hernandez, MD,4
Zulma Trujillo, MD,5 Kjell Hultenby,
PhD,6 Anneli Ring, BS,7
Magnus Soderberg, MD, PhD,7,8
Aurora Arago n, MD, PhD,2
Carl-Gustaf Elinder, MD, PhD,1 and
Annika Wernerson, MD, PhD1,7
2016
Renal Morphology, Clinical Findings, and Progression Rate in
Mesoamerican Nephropathy
Julia Wijkstrom, MD,1 Marvin Gonzalez-Quiroz, MD, MSc,2,3 Mario
Hernandez, MD,4
Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7
Magnus Soderberg, MD, PhD,7,8 Aurora Arago n, MD, PhD,2
Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7
2016